Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency
Laure Gineau, … , Jean-Laurent Casanova, Emmanuelle Jouanguy
Laure Gineau, … , Jean-Laurent Casanova, Emmanuelle Jouanguy
Published February 22, 2012
Citation Information: J Clin Invest. 2012;122(3):821-832. https://doi.org/10.1172/JCI61014.
View: Text | PDF
Research Article

Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency

  • Text
  • PDF
Abstract

Natural killer (NK) cells are circulating cytotoxic lymphocytes that exert potent and nonredundant antiviral activity and antitumoral activity in the mouse; however, their function in host defense in humans remains unclear. Here, we investigated 6 related patients with autosomal recessive growth retardation, adrenal insufficiency, and a selective NK cell deficiency characterized by a lack of the CD56dim NK subset. Using linkage analysis and fine mapping, we identified the disease-causing gene, MCM4, which encodes a component of the MCM2-7 helicase complex required for DNA replication. A splice-site mutation in the patients produced a frameshift, but the mutation was hypomorphic due to the creation of two new translation initiation methionine codons downstream of the premature termination codon. The patients’ fibroblasts exhibited genomic instability, which was rescued by expression of WT MCM4. These data indicate that the patients’ growth retardation and adrenal insufficiency likely reflect the ubiquitous but heterogeneous impact of the MCM4 mutation in various tissues. In addition, the specific loss of the NK CD56dim subset in patients was associated with a lower rate of NK CD56bright cell proliferation, and the maturation of NK CD56bright cells toward an NK CD56dim phenotype was tightly dependent on MCM4-dependent cell division. Thus, partial MCM4 deficiency results in a genetic syndrome of growth retardation with adrenal insufficiency and selective NK deficiency.

Authors

Laure Gineau, Céline Cognet, Nihan Kara, Francis Peter Lach, Jean Dunne, Uma Veturi, Capucine Picard, Céline Trouillet, Céline Eidenschenk, Said Aoufouchi, Alexandre Alcaïs, Owen Smith, Frédéric Geissmann, Conleth Feighery, Laurent Abel, Agata Smogorzewska, Bruce Stillman, Eric Vivier, Jean-Laurent Casanova, Emmanuelle Jouanguy

×

Figure 1

Linkage analysis of NK cell deficiency in humans.

Options: View larger image (or click on image) Download as PowerPoint
Linkage analysis of NK cell deficiency in humans.
(A) Pedigrees of the t...
(A) Pedigrees of the two families. Generations are designated by Roman numerals I–IV. Patients with low counts of NK cells (P1.1, P1.2, P1.3, P1.4, P1.5, and P2.1) are represented by black symbols. The index case is indicated by an arrow. All other family members with normal NK cell counts are indicated by white symbols. A star indicates that the individual has been genotyped for all the microsatellites considered, whereas a circle indicates that genotyping has been carried out only for the 8p12–q12.2 region. Absolute numbers (per mm3 of whole blood) and percentages (% of lymphocytes) of NK cells are indicated for each individual, for the first whole-blood sample analyzed. (B) Multipoint linkage analysis of chromosome region 8p12–q12.2 by homozygosity mapping. Microsatellite positions are indicated in cM. In total, 9 microsatellites were genotyped between D8S1821 and D8S1745. The gray line represents kindred A lod score, and the black line represents the combined lod score for kindreds A and B. (C) Schematic representation of the candidate region (8p11.23–q11.21). The region of interest was delineated between microsatellites D8S1821 and D8S1745. This region is 12 Mb long and contains 1 microRNA and 45 predicted protein-coding genes.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts